Wire · opportunities
AI Is Now Running Clinical Trials. The Question Is Whether Anyone Is Watching.
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 October 2026 · Fusion42 review
AI technologies have shifted from supporting clinical trial analytics to actively operating trials by identifying patients, drafting protocols, and compressing timelines, exemplified by projects like Polaris and ARPA-H's SURPASS program, which aims to collapse traditional trial phases into a seamless process. However, challenges remain regarding compute capacity, data quality, and regulatory oversight frameworks to match AI's operational ambition.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
You must confront how AI is rewriting clinical trial operations by accelerating protocol creation and patient matching, forcing you to upgrade your data systems and oversight now or risk falling behind. The bottleneck is no longer biology but compute and real-time data quality — investing there unlocks the fastest path in trials.
◆ Coverage
1 source · 13 Oct 2026
◆ Related on Wire
◆ Topics